The latest data point for CVS's net income in Q4'25 shows a strong recovery, reaching $2.94B USD, marking a significant rebound from the substantial loss in the prior quarter. Over the period from Q1'23 to Q4'25, net income exhibited volatility with an overall fluctuating trend, starting at $2.14B USD and peaking at $2.26B USD in Q3'23 before declining sharply to a low of -$3.98B USD in Q3'25 due to apparent operational challenges. Year-over-year changes were predominantly negative, with notable declines exceeding -35% in several quarters like Q2'23 and Q1'24, though positive growth of up to 166% occurred in Q3'23 and a robust 79% YoY increase in Q4'25 highlighted resilience. This bar and line chart underscores periods of instability, particularly in 2024-2025, advising analysts to monitor underlying factors such as cost pressures or strategic shifts for future stability.